ask="3.20"
ask_size="800"
average_daily_volume="226073"
bid="3.00"
bid_size="400"
book_value="0.07"
change="-0.15"
change_from_200_day_moving_average="-0.05"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-1.45"
change_From_52_week_low="0.65"
change_in_percent="-4.69%"
close="3.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.98"
ebitda="-30.33M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.10"
ex_dividend_date="N/A"
float_shares="26690000"
high="3.20"
high_52_weeks="4.50"
last_trade_date="2/28/2017"
last_trade_price="3.05"
last_trade_size="8210"
last_trade_time="4:00pm"
low="3.00"
low_52_weeks="2.40"
market_capitalization="138.27M"
moving_average_200_day="3.10"
moving_average_50_day="2.86"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.71%"
percent_change_from_50_day_moving_average="+6.52%"
percent_change_from_52_week_high="-32.22%"
percent_change_from_52_week_low="+27.08%"
previous_close="3.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="44.44"
price_per_sales="11.47"
revenue="12.65M"
shares_outstanding="45333000"
short_ratio="17.80"
stock_exchange="NGM"
symbol="ACRX"
volume="187435"
weeks_range_52="2.40 - 4.50"
